LN: Lymph Node, RP: Radical Prostatectomy, O: Open, R/L: Robot
Assisted/Laparoscopic, ECE: Extracapsular Extension, SV: Seminal
Vesicle, G1: Group 1 (<=3 Months), G2 = Group 2
(>3 Months). * x2 Test
Oncological outcomes like the need for adjuvant treatment, PSA
recurrence and development of metastasis on follow up were similar
between groups in low and intermediate risk patients. (Table 5) In high
risk patients adjuvant treatment need rate was higher in group 1
(p=0.023) whereas there was no statistically significant difference
between groups with respect to metastasis rate and PSA recurrence rate.
(Table 5) Estimated 5-year biochemical recurrence free survival rates
were similar in both groups for all three risk categories. (p=0.700,
0.932 and 0.085 respectively) (Figure 1)
Table 5: Oncological Outcomes